Agile Therapeutics Stock News

The trading price of Agile Therapeutics Inc. (NASDAQ:AGRX) closed lower on Monday, March 07, closing at $0.25, -9.64% lower than its previous close. >> 5 Best Growth Stocks for 2022 << >> 5 Best Growth Stocks for 2022 << Traders who pay close attention to intraday price movement should know that it fluctuated between $0.25 … Making Sense Of Agile Therapeutics Inc.’s (NASDAQ:AGRX) Volatility Read More »

Live Conference Call and Webcast at 4:30 p.m. ET Live Conference Call and Webcast at 4:30 p.m. ET

Live Conference Call and Webcast at 4:30 p.m. ET Live Conference Call and Webcast at 4:30 p.m. ET

Agile Therapeutics Inc. (NASDAQ:AGRX) concluded the trading at $0.35 on Friday, February 04 with a rise of 3.24% from its closing price on previous day. Taking a look at stock we notice that its last check on previous day was $0.34 and 5Y monthly beta was reading 0.99 with its price kept floating in the … Analysts Provide Insight On How High Agile Therapeutics Inc. (AGRX) Can Go Read More »

Agile Therapeutics Inc (AGRX) shares closed 3.0% lower than its previous 52 week low, giving the company a market cap of $48M. The stock is currently down 18.6% year-to-date, down 86.0% over the past 12 months, and down 84.2% over the past five years. This week, the Dow Jones Industrial Average fell 0.9%, and the S&P 500 fell 0.3%. Trading Activity Trading volume this week was 77.6% higher than the 20-day average.Beta, a measure of the stocks volatility relative to the overall market stands at 1.2. Technical Indicators The Relative Strength Index (RSI) on the stock was under 30, indicating it may be underbought.MACD, a trend-following momentum indicator, indicates a downward trend.The stock closed above its Bollinger band, indicating it may be overbought.The stock closed at 3.9% lower than its 5-day moving average, 20.4% lower than its 20-day moving average, and 48.5% lower than its 90-day moving average. Market Comparative Performance The company's share price is the same as the S&P 500 Index , lags it on a 1-year basis, and lags it on a 5-year basis The company's share price is the same as the Dow Jones Industrial Average , lags it on a 1-year basis, and lags it on a 5-year basis The company share price is the same as the performance of its peers in the Health Care industry sector , lags it on a 1-year basis, and lags it on a 5 year basis Per Group Comparative Performance The company's stock price performance year-to-date lags the peer average by 1575.9% The company's stock price performance over the past 12 months lags the peer average by 1400.9% This story was produced by the Kwhen Automated News Generator. For more articles like this, please visit us at finance.kwhen.com. Write to [email protected]. © 2020 Kwhen Inc.

Agile Therapeutics Inc (AGRX) shares closed today at 1.6% above its 52 week low of $0.39, giving the company a market cap of $48M. The stock is currently down 18.7% year-to-date, down 86.2% over the past 12 months, and down 84.5% over the past five years. This week, the Dow Jones Industrial Average fell 0.3%, and the S&P 500 rose 0.6%. Trading Activity Trading volume this week was 6.5% higher than the 20-day average.Beta, a measure of the stocks volatility relative to the overall market stands at 1.2. Technical Indicators The Relative Strength Index (RSI) on the stock was under 30, indicating it may be underbought.MACD, a trend-following momentum indicator, indicates a downward trend.The stock closed above its Bollinger band, indicating it may be overbought. Market Comparative Performance The company's share price is the same as the S&P 500 Index , lags it on a 1-year basis, and lags it on a 5-year basis The company's share price is the same as the Dow Jones Industrial Average , lags it on a 1-year basis, and lags it on a 5-year basis The company share price is the same as the performance of its peers in the Health Care industry sector , lags it on a 1-year basis, and lags it on a 5 year basis Per Group Comparative Performance The company's stock price performance year-to-date lags the peer average by -6080.5% The company's stock price performance over the past 12 months lags the peer average by 1933.2% This story was produced by the Kwhen Automated News Generator. For more articles like this, please visit us at finance.kwhen.com. Write to [email protected]. © 2020 Kwhen Inc.

PRINCETON, N.J., Jan. 05, 2022 (GLOBE NEWSWIRE) -- Agile Therapeutics, Inc. (Nasdaq: AGRX), a women's healthcare company, today announced that Chairman and Chief Executive Officer Al Altomari will

PRINCETON, N.J., Jan. 05, 2022 (GLOBE NEWSWIRE) -- Agile Therapeutics, Inc. (Nasdaq: AGRX), a women's healthcare company, today announced Chairman and Chief Executive Officer Al Altomari will prese

Agile Therapeutics Inc (AGRX) shares closed today at 0.5% above its 52 week low of $0.50, giving the company a market cap of $61M. The stock is currently down 82.5% year-to-date, down 82.9% over the past 12 months, and down 91.8% over the past five years. This week, the Dow Jones Industrial Average rose 3.9%, and the S&P 500 rose 4.9%. Trading Activity Trading volume this week was 4.4% lower than the 20-day average.Beta, a measure of the stocks volatility relative to the overall market stands at 1.1. Technical Indicators The Relative Strength Index (RSI) on the stock was under 30, indicating it may be underbought.MACD, a trend-following momentum indicator, indicates a downward trend.The stock closed below its Bollinger band, indicating it may be oversold. Market Comparative Performance The company's share price is the same as the S&P 500 Index , lags it on a 1-year basis, and lags it on a 5-year basis The company's share price is the same as the Dow Jones Industrial Average , lags it on a 1-year basis, and lags it on a 5-year basis The company share price is the same as the performance of its peers in the Health Care industry sector , lags it on a 1-year basis, and lags it on a 5 year basis Per Group Comparative Performance The company's stock price performance year-to-date lags the peer average by 13495.7% The company's stock price performance over the past 12 months lags the peer average by -24030.9% This story was produced by the Kwhen Automated News Generator. For more articles like this, please visit us at finance.kwhen.com. Write to [email protected]. © 2020 Kwhen Inc.

Analysts expect Agile Therapeutics, Inc. (NASDAQ:AGRX) to report $1.76 million in sales for the current quarter, Zacks Investment Research reports. Two analysts have issued estimates for Agile Therapeutics earnings, with estimates ranging from $1.70 million to $1.81 million. Agile Therapeutics reported sales of $750,000.00 during the same quarter last year, which indicates a positive year []

Agile Therapeutics, Inc. (NASDAQ:AGRX) with the stream of -8.80% also noticed, India CooTek (Cayman) Inc. (NYSE:CTK) encountered a rapid change of -7.41% in the last hour of Fridays trading session. The post Alarming Stock: Agile Therapeutics, Inc. (NASDAQ:AGRX), CooTek (Cayman) Inc. (NYSE:CTK) appeared first on Stocks Equity .

Agile Therapeutics, Inc. (NASDAQ:AGRX) with the stream of -7.72% also noticed, India Teva Pharmaceutical Industries Limited (NYSE:TEVA) encountered a rapid change of 0.37% in the last hour of Tuesdays trading The post Hair-raising Facts to Know: Agile Therapeutics, Inc. (NASDAQ:AGRX), Teva Pharmaceutical Industries Limited (NYSE:TEVA) appeared first on Stocks Equity .

State Street Corp trimmed its stake in Agile Therapeutics, Inc. (NASDAQ:AGRX) by 73.1% in the second quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The fund owned 290,345 shares of the specialty pharmaceutical companys stock after selling 787,565 shares during the quarter. State Street Corp owned approximately []

Agile Therapeutics, Inc. (AGRX) with the stream of -2.52% also noticed, India Galiano Gold Inc. (GAU) encountered a rapid change of 2.52% in the last hour of trading session. Agile The post Have an attention on: Agile Therapeutics, Inc. (NASDAQ:AGRX), Galiano Gold Inc. (AMEX:GAU) appeared first on Stocks Equity .

Millennium Management LLC bought a new stake in Agile Therapeutics, Inc. (NASDAQ:AGRX) during the 2nd quarter, HoldingsChannel reports. The institutional investor bought 1,504,056 shares of the specialty pharmaceutical companys stock, valued at approximately $2,000,000. A number of other large investors have also recently modified their holdings of AGRX. Goldman Sachs Group Inc. raised its holdings []